Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Cognitive Disorders and Serum BDNF/ProBDNF Levels in Cancer Patients Receiving Chemotherapy

NCT07019324 is registered in ClinicalTrials.gov with Cemre Aydeğer as lead sponsor.

NCT NCT07019324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07019324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Cognitive Disorders and Serum BDNF/ProBDNF Levels in Cancer Patients Receiving Chemotherapy
Lead sponsor
Cemre Aydeğer
Phase
Observational
Overall status
Active, not recruiting
Start date
March 17, 2025
Completion date
June 4, 2026
Enrollment
75 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bdnf, chemotherapy, cognitive functions